Foresite Capital Management IV as of June 30, 2025
Portfolio Holdings for Foresite Capital Management IV
Foresite Capital Management IV holds 6 positions in its portfolio as reported in the June 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Pharvaris N V (PHVS) | 62.7 | $78M | 4.4M | 17.60 | |
| Maze Therapeatics (MAZE) | 20.9 | $26M | 2.1M | 12.27 | |
| Lyell Immunopharma (LYEL) | 5.7 | $7.1M | 800k | 8.84 | |
| Xenon Pharmaceuticals (XENE) | 4.0 | $5.0M | 160k | 31.30 | |
| Kura Oncology (KURA) | 3.8 | $4.7M | 817k | 5.77 | |
| Relay Therapeutics (RLAY) | 2.8 | $3.5M | 1.0M | 3.46 |
